Scilex Holding Company Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Scilex Holding Company stock issued during period, shares, new issues for the quarter ending 2025-09-30 was 0.00 shares.
- Scilex Holding Company stock issued during period, shares, new issues for the quarter ending 2025-06-30 was 0.00 shares.
- Scilex Holding Company stock issued during period, shares, new issues for the quarter ending 2025-03-31 was 7.14K shares, a 97.14% decline year-over-year.
- Scilex Holding Company stock issued during period, shares, new issues for the quarter ending 2024-12-31 was 0.00 shares.
- Scilex Holding Company stock issued during period, shares, new issues for fiscal 2024 was 250.00K shares, a 0.00% change from fiscal 2023.
- Scilex Holding Company stock issued during period, shares, new issues for fiscal 2023 was 250.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 7.14K shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 7.14K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 7.14K shares 10-Q · filed 2025-05-14 | 7.14K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 250.00K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | 250.00K shares derived: sum of 4 quarters · filed 2025-01-17 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 250.00K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 250.00K shares 10-Q · filed 2024-05-13 | 250.00K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 250.00K shares 10-K · filed 2024-03-12 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | |
| 2023-03-31 | 250.00K shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |